AbbVie is a leading research-driven global biopharmaceutical company. The company produces drugs for several different therapeutic areas such as rheumatology, oncology, virology, neurology, etc.
AbbVie’s blockbuster drug, Humira is one of the best-selling drugs globally and accounts for nearly 60% of the company’s revenue. The drug is used to treat psoriasis and rheumatoid arthritis. Other key products include Lupron, Creon, Androgel, and Marinol. The company also has a robust late-stage pipeline across several therapeutic areas.
The company has a large distribution network consisting of AbbVie-owned distribution centers and warehouses from where AbbVie's products reach wholesalers, distributors, and government agencies worldwide. AbbVie operates through only one business segment - Pharmaceuticals.
Key Investment Data
- Ticker: nyse:ABBV
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Market Cap: 315.93B
- Market Cap Group: Mega Cap
- P/E: 65.77
- Dividend Yield: 3.47%
- Grade: C
- Dividend Aristocrat: YES
- Chowder Score: Members Only
- Revenue Growth: Members Only
- Dividend Growth: Members Only
- Dividend Growth Fit: 5/10
- Dividend Income Fit: 5/10
Competitors
The competitive landscape is important as they compete for the same business. Below is the list of competitors in the same industry. While not displayed, a number of metrics you can also use to evaluate your picks are the Chowder Score, the Relative Strength Index (RSI), the Graham Number, and the Piotroski F-Score.
| Ticker | Ticker | Company | Market Cap | P/E | Yield | Aristocrat | Graph | SectorID | IndustryID |
|---|---|---|---|---|---|---|---|---|---|
| LLY | NYSE:LLY | Lilly | 724.16 | 131.38 | 0.68 | NO | 1 | 8 | 35 |
| JNJ | NYSE:JNJ | Johnson & Johnson | 384.25 | 30.18 | 2.98 | YES | 1 | 8 | 35 |
| ABBV | NYSE:ABBV | AbbVie Inc | 315.93 | 65.77 | 3.47 | YES | 1 | 8 | 35 |
| MRK | NYSE:MRK | Merck & Co., Inc. | 312.78 | 947.01 | 2.49 | NO | 1 | 8 | 35 |
| PFE | NYSE:PFE | Pfizer Inc. | 153.71 | 75.77 | 6.17 | NO | 1 | 8 | 35 |
| AMGN | NASDAQ:AMGN | Amgen Inc. | 146.71 | 21.92 | 3.29 | NO | 1 | 8 | 35 |
| BMY | NYSE:BMY | Bristol Myers Squibb Co. | 108.77 | 13.94 | 4.46 | NO | 1 | 8 | 35 |
| GILD | NASDAQ:GILD | Gilead Sciences Inc. | 93.58 | 16.68 | 4.10 | NO | 1 | 8 | 35 |
| DHT.UN | TSE:DHT.UN | DIR Healthcare Trust | 0.92 | 0.00 | 2.79 | NO | 1 | 8 | 35 |
AbbVie Inc - FAQ
What is the stock ticker for AbbVie Inc?
The stock ticker for AbbVie Inc is NYSE:ABBV.
Is AbbVie Inc a good stock to buy?
You need to consider your investment strategy and how NYSE:ABBV can fit in your portfolio.
The current dividend income score of 5/10 and dividend growth score of 5/10. Those 2 metrics together should help you decide the fit for your portfolio. Be it for income or for growth.
Is AbbVie Inc a Buy, Sell or Hold?
The Dividend Snapshot Opportunity Score of 49 out of 100.
The score reflects the strength of a buy signal but it does not show a sell signal if it's low. The higher the better.
A sell signal is more difficult as it often relies on the reason you bought the stock in the first place.
How can I buy stocks for AbbVie Inc?
You can easily buy the ABBV stock with an online trading platform.
Just make sure the stock fits your risk profile and investment goals.